
The FDA approved ansuvimab-zykl (Ebanga; Ridgeback Biotherapeutics) for the treatment of Zaire ebolavirus (Ebolavirus) infection in adults and children.
The FDA approved ansuvimab-zykl (Ebanga; Ridgeback Biotherapeutics) for the treatment of Zaire ebolavirus (Ebolavirus) infection in adults and children.
In a session held during ASHP Midyear 2020 Clinical Meeting & Exhibition, Anthony Fauci, MD, warned pharmacists of challenging months ahead amid the COVID-19 pandemic.
Incidents of medication theft, including theft of COVID-19 treatments, could jeopardize operations and hurt patients.
Pharmacists can prepare themselves to address patients’ questions and concerns about the COVID-19 vaccines.
A look back at the most impressive drug approvals and product launches of the year.
Mail-order prescriptions shipped during winter and summer months are likely to spend a substantial portion of time outside the recommended safe temperature range for most medications.
A poster presentation from ASHP Midyear 2020 Clinical Meeting & Exhibition highlighted the pharmacist’s role in improving outcomes in patients with COPD.
In a virtual session held during the ASHP Midyear 2020 Clinical Meeting & Exhibition, experts discussed updates in asthma management, including new data and upcoming guideline changes that will impact pharmacy practice.
Award winning actor Tom Hanks addressed pharmacists during the ASHP Midyear 2020 Clinical Meeting & Exhibition.
A poster presented at the ASHP 2020 Midyear Clinical Meeting & Exhibition highlighted the success of an in-pharmacy pneumococcal immunization campaign.
Each year, Drug Topics® surveys pharmacists on important workplace issues—from compensation encompassing salary, wages, and raises to stress levels and overall job satisfaction.
The FDA approved azacitidine tablets (Onureg; Celgene Corporation) on September 1, 2020
Pharmacists may be among the first of the prioritized groups to be offered the COVID-19 vaccine once it receives FDA authorization.
A survey conducted by the American Pharmacists Association asked pharmacists if they were ready to receive and administer COVID-19 vaccines.
The new model will test a new way to lower increasing drug prices for patients paying for drugs under Medicare Part B.
A study presented during PAINWeek 2020 Live Virtual Conference highlights the role of e-consultations in reducing opioid use.
“This first-generation polypill is not magic, but it would be clinically worthwhile.”
Many opportunities exist for pharmacists within the multidisciplinary care team to ensure the delivery of optimal cancer care.
Shared information and continued communication can build a cohesive partnership.
A webcast hosted by the Association of Black Cardiologists addresses barriers to enhancing diversity in medicine and identifies the potential solutions.
Controlling exposure to antibiotics is important for stewardship programs, and even more so in neonatal intensive care units.
The agency warns that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby.
Oliceridine (Olinvyk; Trevena, Inc) is an intravenous opioid agonist indicated in adults for management of acute severe pain in a hospital or controlled clinical setting.
Bill SB 852 would address the affordability and accessibility of generic drugs, including insulin and epinephrine, in California.
Unfortunately, even though the need for making proper dose adjustments for kidney function is well-recognized, clinicians face many challenges in doing so.